Join our daily newsletter At The Bell to receive exclusive market insights
- New Zealand Coastal Seafoods (NZS) successfully commercialises a new hydrolysed marine collagen powder for the nutraceuticals market
- The collagen will be extracted from Ling maw which is the swim bladder of the Ling fish and is harvested from waters around southern New Zealand
- Commercialisation follows completion of extraction trials using the hydrolysed process which is more efficient and cheaper with results significantly exceeding expectations
- Commercial production will begin shortly and NZS is in discussions with various consumer product companies
- NZS shares are trading 11.1 per cent higher at 0.5 cents at 1:37 pm AEST
New Zealand Coastal Seafoods (NZS) has successfully commercialised a new hydrolysed marine collagen powder for the nutraceuticals market.
The collagen will be extracted from Ling maw which is the swim bladder of the Ling fish and is harvested from waters around southern New Zealand.
It is recognised as one of the world’s richest protein foods with collagen making up more than 90 per cent of its content.
NZS believes the product will be among one of the highest quality collagen powders available as a human dietary supplement.
Commercialisation follows the completion of extraction trials using the hydrolysed process which is more efficient and cheaper with results significantly exceeding expectations.
The process breaks down the Ling maw-sourced protein into smaller particles so it dissolves easier in water and easily absorbed into the body.
Commercial production will begin shortly and NZS is in discussions with various consumer product companies.
“Commercialisation of the new flagship marine collagen powder is a major milestone for the company. It follows the successful completion of extraction trials using the new hydrolysis process developed for us exclusively by Medical Collagen New Zealand, who are a leading collagen researcher in this country,” CEO Andrew Peti said.
“Our product has a multitude of unique selling points, giving us a significant competitive advantage in the collagen market.
“NZCS has dispatched samples to various wholesalers and distributors globally, and we are advancing discussions with customers. We anticipate strong demand and sales over the next 12 months now we can supply the product on a commercial basis.”
NZS shares were 11.1 per cent in the green and trading at 0.5 cents at 1:37 pm AEST.
